Virus complement evasion strategies

被引:84
作者
Favoreel, HW [1 ]
Van de Walle, GR [1 ]
Nauwynck, HJ [1 ]
Pensaert, MB [1 ]
机构
[1] Univ Ghent, Virol Lab, Fac Vet Med, B-9820 Merelbeke, Belgium
关键词
D O I
10.1099/vir.0.18709-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The immune system has a variety of tools at its disposal to combat virus infections. These can be subdivided roughly into two categories: 'first line defence', consisting of the non-specific, innate immune system, and 'adaptive immune response', acquired over time following virus infection or vaccination. During evolution, viruses have developed numerous, and often very ingenious, strategies to counteract efficient recognition of virions or virus-infected cells by both innate and adaptive immunity. This review will focus on the different strategies that viruses use to avoid recognition by one of the components of the immune system: the complement system. Complement evasion is of particular importance for viruses, since complement activation is a crucial component of innate immunity (alternative and mannan-binding lectin activation pathway) as well as of adaptive immunity (classical, anti body-dependent complement activation).
引用
收藏
页码:1 / 15
页数:15
相关论文
共 108 条
[61]   Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo [J].
Lubinski, JM ;
Wang, LY ;
Soulika, AM ;
Burger, R ;
Wetsel, RA ;
Colten, H ;
Cohen, GH ;
Eisenberg, RJ ;
Lambris, JD ;
Friedman, HM .
JOURNAL OF VIROLOGY, 1998, 72 (10) :8257-8263
[62]   Human cytomegalovirus induces an Fc gamma receptor (Fc(gamma)R) in endothelial cells and fibroblasts that is distinct from the human cellular Fc(gamma)Rs [J].
MacCormac, LP ;
Grundy, JE .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1151-1161
[63]   IMMUNOREACTIVITY OF CYTOMEGALOVIRUS-INDUCED FC-RECEPTORS [J].
MACKOWIAK, PA ;
MARLINGCASON, M .
MICROBIOLOGY AND IMMUNOLOGY, 1987, 31 (05) :427-434
[64]   Pseudorabies virus (PRV) is protected from complement attack by cellular factors and glycoprotein C (gC) [J].
Maeda, K ;
Hayashi, S ;
Tanioka, Y ;
Matsumoto, Y ;
Otsuka, H .
VIRUS RESEARCH, 2002, 84 (1-2) :79-87
[65]   REGULATION OF COMPLEMENT ACTIVITY BY VACCINIA VIRUS COMPLEMENT-CONTROL PROTEIN [J].
MCKENZIE, R ;
KOTWAL, GJ ;
MOSS, B ;
HAMMER, CH ;
FRANK, MM .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (06) :1245-1250
[66]   DISCRIMINATION BETWEEN ACTIVATORS AND NONACTIVATORS OF THE ALTERNATIVE PATHWAY OF COMPLEMENT - REGULATION VIA A SIALIC-ACID POLYANION BINDING-SITE ON FACTOR-H [J].
MERI, S ;
PANGBURN, MK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (10) :3982-3986
[67]   INTERACTION OF GLYCOPROTEIN-GIII WITH A CELLULAR HEPARINLIKE SUBSTANCE MEDIATES ADSORPTION OF PSEUDORABIES VIRUS [J].
METTENLEITER, TC ;
ZSAK, L ;
ZUCKERMANN, F ;
SUGG, N ;
KERN, H ;
BENPORAT, T .
JOURNAL OF VIROLOGY, 1990, 64 (01) :278-286
[68]   KILLING OF HUMAN CYTOMEGALOVIRUS-INFECTED FIBROBLASTS BY ANTIVIRAL ANTIBODY AND COMPLEMENT [J].
MIDDELDORP, JM ;
JONGSMA, J ;
THE, TH .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (01) :48-55
[69]   EPSTEIN-BARR VIRUS REGULATES ACTIVATION AND PROCESSING OF THE 3RD COMPONENT OF COMPLEMENT [J].
MOLD, C ;
BRADT, BM ;
NEMEROW, GR ;
COOPER, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (03) :949-969
[70]   In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor [J].
Nagashunmugam, T ;
Lubinski, J ;
Wang, LY ;
Goldstein, LT ;
Weeks, BS ;
Sundaresan, P ;
Kang, EH ;
Dubin, G ;
Friedman, HM .
JOURNAL OF VIROLOGY, 1998, 72 (07) :5351-5359